Key result
PRS show potential to enhance cardiovascular risk stratification beyond traditional factors despite clinical implementation gaps.
Why the study?
The sudden and often fatal onset of many cardiovascular diseases calls for improved risk prediction and personalized preventive strategies, where polygenic risk scores may add precision to guideline-recommended clinical risk scores.
Does the integration of polygenic risk scores (PRS) with clinical risk assessment improve risk prediction and personalized preventive strategies in cardiovascular disorders?
Does the integration of polygenic risk scores (PRS) with clinical risk assessment improve risk prediction and personalized preventive strategies in cardiovascular disorders?
Polygenic risk scores offer the potential to enhance traditional guideline-recommended clinical risk assessments by providing individualized genetic risk estimates, though clinical implementation requires further prospective validation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for polygenic risk scores in cardiovascular stratification; prospective trials needed before clinical adoption.
The sudden and often fatal onset of many cardiovascular disease (CVD) calls for improved risk prediction and personalized preventive strategies. Polygenic risk score (PRS) captures inherited susceptibility and may add precision to guideline-recommended clinical risk score. Given the spectrum of CVD, the utility of PRS varies from being a clinically meaningful diagnostic tool to a scientific instrument that brings light into the complex aetiologies. This review summarizes the current understanding of PRS in CVD. We discuss methodological strategies for its construction and outline clinical scenarios for PRS across major CVDs, including coronary artery disease, aortic aneurysms, cardiomyopathies, atrial fibrillation in the context of heart failure, and hypertension, highlighting their potential to enhance risk stratification beyond traditional factors. Finally, we outline current knowledge gaps that limit the clinical implementation of PRS.
No takes yet. Share an insight, caveat, or question.
Schunkert et al. (2026) conducted a review in Cardiovascular disorders. Polygenic risk scores (PRS) vs. Traditional clinical risk factors was evaluated. Polygenic risk scores enhance cardiovascular risk stratification beyond traditional factors, identifying individuals at high genetic risk and potentially reclassifying intermediate-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: